Jounce Therapeutics, Inc. (JNCE) Q2 2020 Earnings Call Transcript
Speaking on today's call will be our CEO and President, Dr. Rich Murray, who will discuss our progress in key milestones, followed by our CMO, Dr. Beth Trehu, who will provide an update on our clinical activities. Before we begin, I would like to remind everyone that today's discussion will include statements about our future expectations, plans and prospects that constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
